-
Clinical and Experimental Gastroenterology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Maspin is a deoxycholate-inducible, anti-apoptotic stress-response protein differentially expressed during colon carcinogenesis
Original Research
(666) Views (172) Full article downloads
Authors: Payne CM, Holubec H, Crowley-Skillicorn C, Nguyen H, Bernstein H, Wilcox G, Bernstein C
Published Date October 2011
Volume 2011:4 Pages 239 - 253
DOI: http://dx.doi.org/10.2147/CEG.S24093
Claire M Payne1,2, Hana Holubec1, Cheray Crowley-Skillicorn1, Huy Nguyen1, Harris Bernstein1, George Wilcox3, Carol Bernstein11Department of Cellular and Molecular Medicine, College of Medicine, University of Arizona, 2Biomedical Diagnostics and Research, Inc, 3Tucson Medical Center, Pathology, Tucson, AZ, USA
Abstract: Increased maspin expression in the colon is related to colon cancer risk and patient survival. Maspin is induced by the hydrophobic bile acid, deoxycholate (DOC), which is an endogenous carcinogen and inducer of oxidative stress and DNA damage in the colon. Persistent exposure of colon epithelial cells, in vitro, to high physiologic levels of DOC results in increased constitutive levels of maspin protein expression associated with the development of apoptosis resistance. When an apoptosis-resistant colon epithelial cell line (HCT-116RC) developed in the authors' laboratory was treated with a maspin-specific siRNA probe, there was a statistically significant increase in apoptosis compared to treatment with an siRNA control probe. These results indicate, for the first time, that maspin is an anti-apoptotic protein in the colon. Immunohistochemical evaluation of maspin expression in human colonic epithelial cells during sporadic colon carcinogenesis (131 human tissues evaluated) indicated a statistically significant increase in maspin protein expression beginning at the polyp stage of carcinogenesis. There was no statistically significant difference in maspin expression between hyperplastic/adenomatous polyps and colonic adenocarcinomas. The absence of "field defects" in the non-neoplastic colonic mucosa of patients with colonic neoplasia indicates that maspin may drive the growth of tumors, in part, through its anti-apoptotic function.
Keywords: maspin, anti-apoptotic, bile acid-inducible, immunohistochemistry, colon cancer
Other articles by Dr Claire Payne
Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis
Readers of this article also read:
Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite®) solution in the treatment of ocular infections
Effects of a cellulose mask synthesized by a bacterium on facial skin characteristics and user satisfaction
A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
Similarity of hydrolyzing activity of human and rat small intestinal disaccharidases
Comparator pH study to evaluate the single-dose pharmacodynamics of dual delayed-release dexlansoprazole 60 mg and delayed-release esomeprazole 40 mg
Relation between ABO blood groups and Helicobacter pylori infection in symptomatic patients
Association between optic nerve blood flow and objective examinations in glaucoma patients with generalized enlargement disc type
Weight loss in elderly women in low-level care and its association with transfer to high-level care and mortality
Update on celiac disease – etiology, differential diagnosis, drug targets, and management advances
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Amino acid-responsive Crohn's disease: a case study
- Oropharyngeal Crohn’s disease
- Methylnaltrexone in the treatment of opioid-induced constipation
- Selected luminal mucosal complications of adult celiac disease




